AI is Transforming Drug Discovery. Here is the Next Trillion-dollar Biotech Opportunity
Quick Read - AI cuts drug discovery from years to weeks, targeting a 10-15 year pipeline where 90% of candidates never reach market approval. - Eli Lilly's tirzepatide franchise generated $36.5 billion in 2025 revenue, a gain of 215%, while Novo Nordisk's GLP-1 portfolio reached...</stron